CORT

#3684
Corcept Therapeutics Incorporated - Common Stock
0.6 9 USD
-98.98%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
0.69
0.69
Intervallo Annuale
0.69
89.00
Variazione giornaliera
-98.98%
Variazione Mensile
-98.52%
Variazione di 6 mesi
-99.11%
Variazione Annuale
-99.05%
Chiusura Precedente
68.3 8
Open
0.6 9
Minimo
0.6 9
High
0.6 9
Volume
220
Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
Conto economico Bilancio Liquidità
Valore Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM

Corcept Therapeutics Incorporated - Common Stock

Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects. Its executive team is headed by CEO, president and director Joseph K. Belanoff, MD.

Notizie